News Focus
News Focus
Followers 1177
Posts 134793
Boards Moderated 3
Alias Born 08/27/2003

Re: Rawnoc post# 3559

Monday, 03/07/2011 12:14:23 AM

Monday, March 07, 2011 12:14:23 AM

Post# of 10861
REPR is the maker of the Freedom60 that delivers the drug Hizentra.

The makers of Hizentra had their earnings release on February and mentioned particularly good results. Their family of immunoglobin drugs grew sales 22%, with CSL noting this was in part due to the increased demand for Hizentra specifically as well as a competitor recently withdrawing itself from the market. As well, CSL announced their additional production capacity is now complete, to support more growth in Hizentra sales.

This should further help explode REPR sales, net income, and EPS.

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today